Public-private partnerships leverage the strengths of both sectors to advance cancer research. These collaborations often result in the development of new technologies, drugs, and treatment protocols. For instance, the Parker Institute for Cancer Immunotherapy collaborates with academic researchers, industry partners, and non-profit organizations to develop innovative immunotherapy treatments.
